Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
Éster Cerdeira Sabino, Lewis Buss, Maria P. S. S. Carvalho, et al.
The Lancet (2021) Vol. 397, Iss. 10273, pp. 452-455
Open Access | Times Cited: 856

Showing 26-50 of 856 citing articles:

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
Pengfei Wang, Manoj S. Nair, Lihong Liu, et al.
(2021)
Open Access | Times Cited: 253
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
Xianding Deng, Miguel Garcia-Knight, Mir M. Khalid, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 238
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species
Ruoke Wang, Qi Zhang, Jiwan Ge, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1611-1621.e5
Open Access | Times Cited: 228
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Carolina Lucas, Chantal B. F. Vogels, İnci Yıldırım, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 523-529
Open Access | Times Cited: 226
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Floriane Gallais, Pierre Gantner, Timothée Bruel, et al.
EBioMedicine (2021) Vol. 71, pp. 103561-103561
Open Access | Times Cited: 212
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 206
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
Alona Kuzmina, Yara Khalaila, Olga Voloshin, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 522-528.e2
Open Access | Times Cited: 192
Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil
Nuno R. Faria, Thomas A. Mellan, Charles Whittaker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 190
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe
Mrinank Sharma, Sören Mindermann, Darren Smith, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 189
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1137-1150.e6
Open Access | Times Cited: 188
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
Alexander C. Dowell, Megan Butler, Elizabeth Jinks, et al.
Nature Immunology (2021) Vol. 23, Iss. 1, pp. 40-49
Open Access | Times Cited: 180
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
Zhengnan Shen, Kiira Ratia, Laura Cooper, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2940-2955
Open Access | Times Cited: 173
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 171
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Vikram Thakur, Shivam Bhola, Pryanka Thakur, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 309-325
Open Access | Times Cited: 167
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna Patel, Kishu Ranjan
Biomolecules (2021) Vol. 11, Iss. 7, pp. 993-993
Open Access | Times Cited: 166
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 161
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study
Matt D. T. Hitchings, Otávio T. Ranzani, Mario Torres, et al.
The Lancet Regional Health - Americas (2021) Vol. 1, pp. 100025-100025
Open Access | Times Cited: 160
SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes
Irwin Jungreis, Rachel Sealfon, Manolis Kellis
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 159
Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York
Medini K. Annavajhala, Hiroshi Mohri, Pengfei Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 156
SARS‐CoV‐2 re‐infection risk in Austria
Stefan Pilz, Ali Chakeri, John P. A. Ioannidis, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 4
Open Access | Times Cited: 150
SARS-CoV-2-specific T cells in infection and vaccination
Antonio Bertoletti, Nina Le Bert, Martin Qui, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2307-2312
Open Access | Times Cited: 150
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
Matthias Becker, Alex Dulovic, Daniel Junker, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 149
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 141
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, et al.
PLoS Medicine (2021) Vol. 18, Iss. 7, pp. e1003656-e1003656
Open Access | Times Cited: 140

Scroll to top